SGRY - Earnings announcements

BRENTWOOD, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2026 results before the market opens on Tuesday, May 5, 2026, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 19, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13760194 Interested investor

BRENTWOOD, Tenn., March 02, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 2.4% for the fourth quarter and 6.2% for the full year Same-facility revenues increased 3.5% for the fourth quarter and 4.9% for the full year Surgical cases decreased 2.1% for the fourth quarter and increased 2.0% for the full year Same-facility cases increased 1.3% for the fourth

BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13758

BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 6.6% for the third quarter Same-facility revenues increased 6.3% for the third quarter Surgical cases increased 2.1% for the third quarter Same-facility cases increased 3.4% for the third quarter Net loss attributable to Surgery Partners, Inc. was $22.7 million for the third quarter Adjusted EBITDA increased 6.1% to

BRENTWOOD, Tenn., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 24, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13756022 Interested

BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 8.4% for the second quarter Same-facility revenues increased 5.1% for the second quarterSame-facility cases increased 3.4% for the second quarter Net loss attributable to Surgery Partners, Inc. was $2.5 million for the second quarter Adjusted EBITDA increased 9.0% to $129.0 million for the second quarter 2025 Guidance

BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2025 results before the market opens on Tuesday, August 5, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-844-826-3033 (domestic), 1-412-317-5185 (international)Replay (available 3 hours after the call and available until August 19, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 10201328 Interested in

BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan

BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor

BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net

BRENTWOOD, Tenn., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2024 results before the market opens on Monday, March 3, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 17, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13751533 Interested inves

BRENTWOOD, Tenn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2024. Revenues increased 14.3% to $770.4 million compared to the prior year period Same-facility revenues increased 4.2%Same-facility cases increased 3.7% Net loss attributable to Surgery Partners, Inc. was $31.7 million Adjusted EBITDA was $128.6 million, representing 21.9% growth compared to the prior year period Adjusted EBITDA margin was 16.7%, expanding 100 basis points from the prior year periodFull year 2024 revenue and Adjusted EBIT

BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2024 results before the market opens on Tuesday, November 12, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 26, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13749078 Intereste

BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024. Revenues increased 14.2% to $762.1 million compared to the prior year period Same-facility revenues increased 9.9%Same-facility cases increased 3.9% Net loss attributable to Surgery Partners, Inc. was $15.5 million Adjusted EBITDA was $118.3 million, representing 18.1% growth compared to the prior year period Adjusted EBITDA margin was 15.5%, expanding 50 basis points from the prior year periodFull year guidance raised to greater than $3.

BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2024 results before the market opens on Tuesday, August 6, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-800-579-2543 (domestic), 1-785-424-1789 (international)Conference ID for the live call: SPI2Q24Replay (available 3 hours after the call and available until August 20, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the replay: 11

BRENTWOOD, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024. Revenues increased 7.7% to $717.4 million compared to the prior year period Same-facility revenues increased 10.2% Net loss attributable to Surgery Partners, Inc. was $12.4 million Adjusted EBITDA was $97.5 million, representing 8.2% growth compared to the prior year period Adjusted EBITDA margin improved year-over-year to 13.6%Full year guidance raised to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA

BRENTWOOD, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 21, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13746011 Interested investor

BRENTWOOD, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2023. Revenue increased 8.0% to $2.74 billion in the full-year 2023 and 4.0% to $735.4 million in the fourth quarter 2023, when compared to the comparable periods in 2022 Days adjusted same-facility revenues increased 11.3% in the full-year 2023 versus 2022Days adjusted same-facility revenues increased 8.1% in the fourth quarter 2023 versus 2022 Net loss attributable to common stockholders was $11.9 million for the full-year 2

BRENTWOOD, Tenn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2023 results before the market opens on Monday, February 26, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 11, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13744429 Interested in

BRENTWOOD, Tenn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. Revenues were $674.1 million representing 8.6% growth Days Adjusted Same-facility revenues increased 14.2% Net loss attributable to Surgery Partners was $4.9 million Adjusted EBITDA was $105.5 million, representing 9.7% growthAdjusted EBITDA margin improved year-over-year to 15.7% Equity earnings in unconsolidated affiliates increased 45.8% to $3.5 million Revenues from facilities not consolidated increased by 71.2% to $159.6 millionAdj

BRENTWOOD, Tenn., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2023 results before the market opens on Tuesday, November 7, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 21, 2023): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13741353 Interested

BRENTWOOD, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. Revenues were $667.6 million representing 8.5% growth and are inclusive of an $8 million cyber event headwind Same-facility revenues increased 8.3% on an unadjusted basis and approximately 10% adjusting for the cyber eventNon-consolidated minority interest revenue increased by over 30% Net income attributable to Surgery Partners was $18.9 million Adjusted EBITDA was $100.2 million, representing 16.4% growthAdjusted EBITDA margin improved by ove

BRENTWOOD, Tenn., July 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2023 results before the market opens on Tuesday, August 1, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until August 15, 2023): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13739956 Interested inv

BRENTWOOD, Tenn., May 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the first quarter ended March 31, 2023. Revenue increased 11.7% from the prior year period to $666.2 million Same-facility revenue increasing 10.3% Net loss attributable to Surgery Partners, Inc. was $24.9 million Adjusted EBITDA of $90.1 million; 17% greater than the prior year periodAdjusted EBITDA margin increased 60 basis points to 13.5% Raises outlook for 2023 Adjusted EBITDA to be greater than $430 million Wayne DeVeydt, Executive Chairman of the Board of Surgery Partners, no

BRENTWOOD, Tenn., April 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2023 results after market close on Monday, May 1, 2023, to be followed by a conference call at 5:00 p.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 15, 2023): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13738145 Interested investors and o

BRENTWOOD, Tenn., March 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter and full year ended December 31, 2022. Revenue increased 15.9% to $707.1 million in the fourth quarter 2022 and 14.1% to $2.5 billion in the full-year 2022, when compared to the comparable periods in 2021 Days adjusted same-facility revenues increased 10.7% in the fourth quarter 2022 versus 2021Days adjusted same-facility revenues increased 7.7% in the full-year 2022 versus 2021 Net loss attributable to common stockholders was $23.4 million for the fourth quarter

BRENTWOOD, Tenn., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2022 results before the market opens on Wednesday, March 1, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 15, 2023): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13735855 Interested in

BRENTWOOD, Tenn., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the third quarter ended September 30, 2022. Revenue increased 11.0% from the prior year period to $620.6 million with same-facility revenues increasing 5.1% Net loss attributable to common stockholders was $25.0 million, with Adjusted EBITDA of $96.2 million; nearly 26% greater than the prior year period Adjusted EBITDA margins increased sequentially and from the prior year period to 15.5% in the quarter Reaffirms projected 2022 Adjusted EBITDA of $375 million to $385 million and anti

BRENTWOOD, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2022 results before the market opens on Tuesday, November 8, 2022, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 22, 2022): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13732757 Interested

Revenue increased 13.3% from the prior year period to $615.4 million Days adjusted same-facility revenues increased 6.9% from the prior year period Net loss attributable to common stockholders was $18.4 million Adjusted EBITDA increased 13.4% over the prior year period to $86.1 million, inclusive of a $0.1 million benefit from the recognition of CARES Act grantsExcluding CARES Act grants, Adjusted EBITDA increased 17.8% over the prior year period, with Adjusted EBITDA margins of 14.0% Reaffirm projected 2022 Adjusted EBITDA in the range of $375 million to $385 million and 2022 revenue in the range of $2.5 billion to $2.6 billion BRENTWOOD, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Surg

BRENTWOOD, Tenn., June 29, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2022 results before the market opens on Tuesday, August 2, 2022, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until August 16, 2022): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13731029 Interested inv

Revenues increased 16.4% to $596.2 million, when compared to the prior year period Days adjusted same-facility revenues increased 8.2% from the prior year periodDays adjusted same-facility case volume increased 6.3% from the prior year period Net income attributable to common stockholders was $12.2 million Adjusted EBITDA increased 5.8% over the prior year period to $77.1 million, inclusive of a $1.0 million benefit from the recognition of CARES Act grantsExcluding CARES Act grants, Adjusted EBITDA increased 22.3% over the prior year period Raising guidance for 2022 Adj

BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2022 results before the market opens on Tuesday, May 3, 2022, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 17, 2022): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13728830 Interested investors

Net loss attributable to common stockholders was $0.1 million for the fourth quarter 2021; $81.2 million for the full-year 2021 Fourth quarter 2021 Adjusted EBITDA increased 26.0% over the prior year period to $114.4 million, inclusive of an $11.6 million benefit from the recognition of CARES Act grantsFull-year 2021 Adjusted EBITDA increased 32.3% over the prior year period to $339.6 million, inclusive of a $25.3 million benefit from the recognition of CARES Act grants Revenues increased 11.3% to $610.2 million in the fourth quarter 2021 and 19.6% to $2.2 billion in the full-year 2021, when compared to the comparable periods in 2020 Days adjusted same-facility revenues increased 9.6% in

BRENTWOOD, Tenn., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2021 results after market close on Monday, February 28, 2022, to be followed by a conference call at 5:00 p.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 2 hours after the call and available until March 14, 2022): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13726849 Interested investo

BRENTWOOD, Tenn., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the third quarter ended September 30, 2021. Revenues increased 12.7% from the prior year period to $559.2 million Days adjusted same-facility revenues increased 8.3% from the prior year periodDays adjusted same-facility case volume increased 6.2% from the prior year period Net loss attributable to common stockholders was $22.9 millionAdjusted EBITDA increased to $76.4 million, growth of approximately 25% over the prior year period2021 full-year adjusted EBITDA guidance increased to $325 million

BRENTWOOD, Tenn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2021 results after market close on Tuesday, November 2, 2021, to be followed by a conference call at 5:00 p.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 2 hours after the call and available until November 16, 2021): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13723444 Interested inve

BRENTWOOD, Tenn., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2021. Revenues increased approximately 45% from the prior year period to $543.3 million Days adjusted same-facility revenues increased 45% from the prior year periodDays adjusted same-facility case volume increased 68% from the prior year period Net loss attributable to common stockholders was $26.9 million Adjusted EBITDA increased to $75.9 million, growth of approximately 30% over the prior year periodA